Quest Diagnostics
DGX
#1086
Rank
โ‚น1.500 T
Marketcap
โ‚น13,447
Share price
2.03%
Change (1 day)
21.54%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2024 (TTM): โ‚น92.86 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น9.53 Billion. In 2023 the company made an earning of โ‚น95.34 Billion a decrease over its 2022 earnings that were of โ‚น104.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น92.86 B-2.6%
2023 โ‚น95.34 B-8.5%
2022 โ‚น104.20 B-52.48%
2021 โ‚น219.29 B37.95%
2020 โ‚น158.96 B75.09%
2019 โ‚น90.78 B16.2%
2018 โ‚น78.13 B-10.1%
2017 โ‚น86.90 B-5.16%
2016 โ‚น91.63 B-1.54%
2015 โ‚น93.06 B31%
2014 โ‚น71.04 B-37.52%
2013 โ‚น113.71 B26.93%
2012 โ‚น89.58 B24.01%
2011 โ‚น72.24 B-27.7%
2010 โ‚น99.92 B-3.55%
2009 โ‚น103.60 B19.59%
2008 โ‚น86.63 B12.54%
2007 โ‚น76.98 B-11.7%
2006 โ‚น87.18 B13.49%
2005 โ‚น76.81 B9.02%
2004 โ‚น70.46 B13.19%
2003 โ‚น62.25 B36.03%
2002 โ‚น45.76 B63.07%
2001 โ‚น28.06 B65.49%
2000 โ‚น16.95 B1297.84%
1999 โ‚น1.21 B-73.37%
1998 โ‚น4.55 B-384.21%
1997 -โ‚น1.61 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น69.38 B-26.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.3 Billion-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น6.45 Billion-106.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.83 Billion-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.51 B-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น12.16 B-87.04%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands